Dr. Raymond Vlacancich, D.O.
Cardiovascular Disease (cardiology)
13+
Years in Practice
Available
Telehealth
Practice Locations
1 location
About Dr. Raymond Vlacancich
Raymond Vlacancich, D.O. is a healthcare provider practicing in Arlington, VA.
Specialty Definition
An internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms.
13
Years Experience
1
Location
1
States Licensed
Credentials & Board Certifications
Additional Specialties
Primary Specialty
Cardiovascular Disease (cardiology)Credentials verified via NPI Registry (NPPES)
Education & Training
Medical School
New York College Of Osteo Medicine Of New York Institute Of Technology
Class of 2013
Licenses & Practice States
Licensed in 1 state
| State | License | Classification | Primary |
|---|---|---|---|
| Virginia | 0102204410 | Nuclear Medicine | — |
| Virginia | 0102204410 | Internal Medicine |
Public Data Summary for Dr. Raymond Vlacancich
With 13 years of practice, Dr. Raymond Vlacancich is an established cardiovascular disease (cardiology) provider, D.O., after earning their medical degree at New York College Of Osteo Medicine Of New York Institute Of Technology in 2013. Dr. currently practices at Arlington Dermatology, Pllc in Arlington, Virginia. Their National Provider Identifier (NPI) is 1457694630, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
CMS Medicare data shows Dr. Raymond Vlacancich as a high-volume cardiovascular disease (cardiology) provider, treating approximately 2K Medicare beneficiaries and delivering 4K services in the most recent reporting year. That panel size indicates sustained experience with complex Medicare cases.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Raymond Vlacancich received $314 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$314
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Raymond Vlacancich
--
0 reviews
Cardiovascular Disease (cardiology) Providers Nearby
Same primary specialty near ZIP 22201
Dr. Warren Levy, M.D.
Cardiovascular Disease (cardiology)
Dr. Antonio Parente, M.D.
Cardiovascular Disease (cardiology)
Aditi Bhagat, MD, MPH
Cardiovascular Disease (cardiology)
Dr. Timothy Farrell, M.D.
Cardiovascular Disease (cardiology)
Dr. Michael Notarianni, M.D.
Cardiovascular Disease (cardiology)
Dr. Dean Carpousis, MD
Cardiovascular Disease (cardiology)
FAQ
Frequently asked questions about Dr. Raymond Vlacancich
What does Dr. Raymond Vlacancich specialize in?
Dr. Raymond Vlacancich specializes in Cardiovascular Disease (cardiology). Secondary taxonomy filings also list Nuclear Medicine.
Where does Dr. Raymond Vlacancich practice?
Dr. Raymond Vlacancich practices at Arlington Dermatology, Pllc in Arlington, Virginia.
Does Dr. Raymond Vlacancich accept Medicare?
CMS records show that Dr. Raymond Vlacancich accepts Medicare assignment. CMS billing data shows 2K Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Raymond Vlacancich's NPI number?
Dr. Raymond Vlacancich's National Provider Identifier (NPI) is 1457694630. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Raymond Vlacancich been practicing?
Dr. Raymond Vlacancich has approximately 13 years of practice experience, having graduated from New York College Of Osteo Medicine Of New York Institute Of Technology in 2013.